Lexaria Bioscience Corp (LEXX)
2.18
-0.06
(-2.68%)
USD |
NASDAQ |
Apr 24, 15:21
Lexaria Bioscience Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| November 30, 2023 | 96.81% |
| August 31, 2023 | |
| May 31, 2023 | 86.32% |
| February 28, 2023 | 85.23% |
| November 30, 2022 | 83.84% |
| August 31, 2022 | 62.89% |
| May 31, 2022 | 81.31% |
| February 28, 2022 | 79.16% |
| November 30, 2021 | 59.87% |
| August 31, 2021 | 34.53% |
| May 31, 2021 | 70.60% |
| February 28, 2021 | 84.08% |
| November 30, 2020 | 78.19% |
| August 31, 2020 | 38.05% |
| May 31, 2020 | 44.21% |
| February 29, 2020 | -54.75% |
| November 30, 2019 | 23.99% |
| August 31, 2019 | 88.05% |
| May 31, 2019 | 94.83% |
| February 28, 2019 | 82.47% |
| November 30, 2018 | 90.28% |
| August 31, 2018 | 96.94% |
| May 31, 2018 | 98.27% |
| February 28, 2018 | 92.03% |
| November 30, 2017 | 75.24% |
| Date | Value |
|---|---|
| August 31, 2017 | 61.72% |
| May 31, 2017 | 68.61% |
| February 28, 2017 | -18.01% |
| November 30, 2016 | 90.37% |
| August 31, 2016 | 68.63% |
| May 31, 2016 | -49.78% |
| February 29, 2016 | -26.94% |
| November 30, 2015 | -33.34% |
| August 31, 2015 | -291.6% |
| May 31, 2015 | -34.84% |
| February 28, 2015 | 28.82% |
| November 30, 2014 | |
| July 31, 2014 | 39.57% |
| April 30, 2014 | 34.28% |
| January 31, 2014 | 20.85% |
| October 31, 2013 | 34.19% |
| July 31, 2013 | 30.28% |
| April 30, 2013 | 34.84% |
| January 31, 2013 | 36.51% |
| October 31, 2012 | 43.38% |
| July 31, 2012 | 53.62% |
| April 30, 2012 | 1.18% |
| January 31, 2012 | 41.77% |
| October 31, 2011 | 64.14% |
| July 31, 2011 | 53.21% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-54.75%
Minimum
Feb 2020
96.81%
Maximum
Nov 2023
63.18%
Average
78.68%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 88.04% |
| Sunshine Biopharma Inc | 33.44% |
| Acasti Pharma Inc | -- |
| Edesa Biotech Inc | -- |
| Xenon Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -130.3% |
| Return on Assets | -117.5% |
| Return on Invested Capital | -130.3% |
| Profit Margin (Quarterly) | -448.0% |
| Operating Margin (Quarterly) | -460.7% |
| Return on Net Operating Assets | -122.3% |